Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SD Guthrie, rebranded from Sime Darby Plantation in 2024, is a global leader in integrated palm oil production and a pioneer in agricultural biotechnology. The company distinguished itself in the life sciences sector by becoming the first to sequence the oil palm genome, leading to the development of its GenomeSelect platform for high-yielding crop varieties. Beyond its core agribusiness, SD Guthrie operates a significant downstream division, SD Guthrie International, which produces high-purity phytonutrients such as tocotrienols (Vitamin E) for the pharmaceutical and nutraceutical industries. The company maintains a dedicated Technology Centre focused on genomics, tissue culture, and molecular breeding to drive sustainability and yield optimization. Headquartered in Malaysia, SD Guthrie operates across the entire value chain, from upstream R&D and plantations to specialized health-related ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SD Guthrie.